トップページ > 産学連携推進部 > 研究実績 > 2022年 研究業績
2022年 研究業績
- Y Kurasawa, A Iida, K Narimatsu, H Sekiya, Y Maruoka and Y Michiwaki.
Effects of Perioperative Oral Management in Patients with Cancer.
J Clin Med 11(21).
https://doi.org/10.3390/jcm11216576 - J S Takeuchi, A Fukunaga, S Yamamoto, A Tanaka, K Matsuda, M Kimura, A Kamikawa, Y Kito, K Maeda, G Ueda, T Mizoue, M Ujiie, H Mitsuya, N Ohmagari and W Sugiura.
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study.
Sci Rep 12(1): 15447.
https://doi.org/10.1038/s41598-022-19581-y - N Okumura, S Saito, Y Takamatsu, J S Takeuchi, Y Asai, M Sanada, N Iwamoto, K Maeda, H Mitsuya and N Ohmagari.
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.
J Infect Chemother 28(12): 1704-1706.
https://doi.org/10.1016/j.jiac.2022.08.026 - H Yahara, S Yanamoto, M Takahashi, Y Hamada, H Sakamoto, T Asaka, Y Kitagawa, K Moridera, K Noguchi, M Sugiyama, Y Maruoka and K Yahara.
Whole blood transcriptome profiling identifies gene expression subnetworks and a key gene characteristic of the rare type of osteomyelitis.
Biochem Biophys Rep 32: 101328.
https://doi.org/10.1016/j.bbrep.2022.101328 - S Nishijima, N Nagata, Y Kiguchi, Y Kojima, T Miyoshi-Akiyama, M Kimura, M Ohsugi, K Ueki, S Oka, M Mizokami, T Itoi, T Kawai, N Uemura and M Hattori.
Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort.
Nat Commun 13(1): 5252.
https://doi.org/10.1038/s41467-022-32832-w - S Saito, P T N Thao, M Ishikane, P T Xuan, S Kutsuna, H Q Dai, H Ohtsu, T Kimura, H Kiyohara, Y Shimada, Y Maruoka, P T P Thuy, T T Phu, H K Phuong, T T Tra, N L M Duy, H Ohara, H Kurosu, N T Son and N Ohmagari.
Physical oral care prevents ventilator-associated pneumonia in Vietnam: A prospective interventional study.
J Infect Chemother 28(12): 1632-1638.
https://doi.org/10.1016/j.jiac.2022.08.017 - Y Terayama, N Tomita, J Terada-Hirashima, Y Uemura, Y Shimizu, J S Takeuchi, Y Takamatsu, K Maeda, A Mikami, M Ujiie and W Sugiura.
Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA).
Life (Basel) 12(7).
https://doi.org/10.3390/life12070966 - Y Shimada, Y Shiko, F Nakamura, A Hangaishi, Y Kawasaki and Y Maruoka.
Mental foramen in panoramic radiography can be a reference for discrimination of punched-out lesions in the mandible in patients with symptomatic multiple myeloma: A cross-sectional study.
Glob Health Med 4(3): 186-191.
https://doi.org/10.35772/ghm.2021.01110 - J Terada-Hirashima, W Sugiura, Y Shimizu, Y Tanaka, Y Uemura, M Ishikane, Y Kazuyama, M Ikeda, K Wakabayashi, N Ohmagari and M Kimura.
Investigation of the use of PCR testing prior to ship boarding to prevent the spread of SARS-CoV-2 from urban areas to less-populated remote islands.
Glob Health Med 4(3): 174-179.
https://doi.org/10.35772/ghm.2022.01008 - N Nagata, S Nishijima, T Miyoshi-Akiyama, Y Kojima, M Kimura, R Aoki, M Ohsugi, K Ueki, K Miki, E Iwata, K Hayakawa, N Ohmagari, S Oka, M Mizokami, T Itoi, T Kawai, N Uemura and M Hattori.
Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome.
Gastroenterology 163(4): 1038-1052.
https://doi.org/10.1053/j.gastro.2022.06.070 - N Okumura, S Tsuzuki, S Saito, S I Hattori, J S Takeuchi, T Saito, M Ujiie, M Hojo, N Iwamoto, W Sugiura, H Mitsuya and N Ohmagari.
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan.
J Infect Chemother 28(9): 1340-1343.
https://doi.org/10.1016/j.jiac.2022.04.018 - S S Khor, Y Omae, J S Takeuchi, A Fukunaga, S Yamamoto, A Tanaka, K Matsuda, M Kimura, K Maeda, G Ueda, T Mizoue, M Ujiie, H Mitsuya, N Ohmagari, W Sugiura and K Tokunaga. An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine.
Vaccines (Basel) 10(4).
https://doi.org/10.3390/vaccines10040563 - N Nagata, S Nishijima, Y Kojima, Y Hisada, K Imbe, T Miyoshi-Akiyama, W Suda, M Kimura, R Aoki, K Sekine, M Ohsugi, K Miki, T Osawa, K Ueki, S Oka, M Mizokami, E Kartal, T S B Schmidt, E Molina-Montes, L Estudillo, N Malats, J Trebicka, S Kersting, M Langheinrich, P Bork, N Uemura, T Itoi and T Kawai.
Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study.
Gastroenterology 163(1): 222-238.
https://doi.org/10.1053/j.gastro.2022.03.054 - M Ueno, N Iwata-Yoshikawa, A Matsunaga, T Okamura, S Saito, S Ashida, I Yoshida, M Nagashima, H Asakura, Y Yaoita, J Suzuki, K Sadamasu, K Yoshimura, S Kutsuna, N Shiwa-Sudo, N Nagata, T Suzuki, A Suzuki, M Okamoto, M Kimura, N Ohmagari, R Miura and Y Ishizaka.
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.
Antiviral Res 201: 105297.
https://doi.org/10.1016/j.antiviral.2022.105297 - Y Miyazato, K Yamamoto, Y Nakaya, S Morioka, J S Takeuchi, Y Takamatsu, K Maeda, M Kimura, W Sugiura, H Mitsuya, M Yano and N Ohmagari.
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.
J Infect Chemother 28(7): 991-994.
https://doi.org/10.1016/j.jiac.2022.03.002 - Y Maruoka, Y Michiwaki, H Sekiya, Y Kurasawa and N Natsume
What does oral care mean to society?
Biosci Trends 16(1): 7-19.
https://doi.org/10.5582/bst.2022.01046 - M Ishikane, H Unoki-Kubota, A Moriya, S Kutsuna, H Ando, Y Kaburagi, T Suzuki, N Iwamoto, M Kimura and N Ohmagari.
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19.
J Infect Chemother 28(6): 729-734.
https://doi.org/10.1016/j.jiac.2022.02.004 - S Yamamoto, A Fukunaga, A Tanaka, J S Takeuchi, Y Inoue, M Kimura, K Maeda, G Ueda, T Mizoue, M Ujiie, W Sugiura and N Ohmagari.
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine 40(13): 1924-1927.
https://doi.org/10.1016/j.vaccine.2022.02.052 - S Yamamoto, K Maeda, K Matsuda, A Tanaka, K Horii, K Okudera, J S Takeuchi, T Mizoue, M Konishi, M Ozeki, H Sugiyama, N Aoyanagi, H Mitsuya, W Sugiura and N Ohmagari.
Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
Clin Infect Dis 75(1): e683-e691.
https://doi.org/10.1093/cid/ciab1048 - 木藤 嘉彦, 山本 重則, 石井 勉, 村田 博昭, 丸箸 圭子, 遠藤 尚宏, 竹内 (柴田) 潤子, 椎野 禎一郎, 木村 基 and 杉浦 亙.
重症心身障害児者の新型コロナワクチン免疫原性による有効性評価 抗体価・T細胞応答性(共同研究中間報告).
日本重症心身障害学会誌 = Journal of severe motor and intellectual disabilities 47(1): 61-64.
https://cir.nii.ac.jp/crid/1520855132307662080